Navigation Links
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
Date:3/12/2009

Provides first affordable protease inhibitor for patients in developing countries Complements recent WHO approval earned for the same product

PITTSBURGH, March 12 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.5% controlling interest, has received the first and only tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Lopinavir/Ritonavir Tablets, 200 mg/50 mg. Matrix's version of this product is heat-stable and affordable, making it practical for distribution and use in warm climates.

Mylan Vice Chairman and CEO Robert J. Coury said: "Mylan and Matrix are committed to our growing and high quality antiretroviral franchise. Our goal is to provide HIV treatments to patients around the world -- especially in developing countries. With Matrix's heat-stable and affordable version of Lopinavir/Ritonavir, patients in remote parts of developing nations will have access to this important life-saving drug. This is the second regulatory approval that this important product has recently earned, which further confirms our commitment to providing high-quality medicines at affordable prices."

Lopinavir/Ritonavir Tablets are the generic version of Abbott Laboratories' Kaletra(R) Tablets, the brand marketed in the U.S. and Europe, and Aluvia(R) Tablets, the brand marketed in developing countries. It is used in combination with other medications to control HIV infection and is included in the antiretroviral (ARV) class of drugs known as HIV protease inhibitors.

Last month, Matrix was awarded the first and only World Health Organization (WHO) approval for the same product. These approvals
'/>"/>

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. CorMatrix Cardiovascular Announces First European Implants of CorMatrix(R) ECM Technology(TM)
2. Mylans Matrix Receives WHO Approval for First Generic, Heat-Stable Version of HIV Protease Inhibitor
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 21st Annual OC Growth Stock Conference
4. Matrixx Initiatives, Inc. Reports Third-Quarter Net Sales Increased 26% to $38.7 Million, Net Income Increased to $4.8 Million, or $0.50 Earnings Per Share
5. Matrixx Initiatives, Inc. Sets Time for Discussion of Third Quarter Fiscal 2009 Financial Results
6. Matrixx Initiatives Selects GolinHarris as Agency of Record for Zicam Brand
7. Mylans Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
8. BioNanomatrix Appoints Gary Zweiger, Ph.D., as Vice President of Business Development
9. Mylans Matrix First-to-File on Generic Version of Vfend(R) Antifungal
10. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
11. Matrixx Initiatives, Inc. Announces Fiscal 2008 Revenue of $101 Million and Net Income Growth of 59% to $10.4 Million, or $1.04 Earnings Per Share Versus $0.66 in the Prior Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... 2015 The joint venture between Dignity ... emergency room in Chandler on Friday, May 1st. The ... which is also part of the Dignity Health and ... Dignity Health Arizona General Hospital Emergency Room hosted a ... and donated $5,000 to Campo Verde High School. ...
(Date:5/5/2015)... Falls Church, VA (PRWEB) May 06, 2015 ... with FDA Regulations, Make Social Media Your Most Powerful ... 24-25, 2015 – Washington, DC, http://www.fdanews.com/SocialMedia , ... , Marketers dream of social media’s reach. Patients are ... talking to their doctors about what they’ve discovered. , ...
(Date:5/5/2015)... Khaimah, UAE (PRWEB) May 05, 2015 ... Century , FZ LLC has announced that its dental ... enrollment for Store-A-Tooth™ increased once again--in April, 2015 –and ... 40th month of increased record volume and represents a ... for Provia’s dental stem cell biobank is conducted via ...
(Date:5/5/2015)... 2015 NCPDP announced today that ... program establishes a three-year commitment of strategic support for ... Elite Partners. “AmerisourceBergen has supported our multi-stakeholder forum over ... “and this is a wonderful continuation and expansion of ... trace AmerisourceBergen back to our very first Board of ...
(Date:5/5/2015)... New York, NY (PRWEB) May 05, 2015 ... Maternity Health IVF Clinic in Greece, an experienced ... evaluation and treatment of infertility for patients around the ... has partnered with VisitandCare.com. Greece unquestionably remains a global ... the most talented and hard-working fertility specialists in the ...
Breaking Medicine News(10 mins):Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 2Health News:Dignity Health and Adeptus Health Opened First Freestanding Emergency Room in Chandler, Arizona 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 2Health News:Grace Century’s Dental Stem Cell Biobank Project Announces Serial Record Enrollment Growth 3Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 2Health News:AmerisourceBergen Joins NCPDP Elite Partner Program 3Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 2Health News:Maternity Health IVF Clinic in Greece Demonstrates Industry-Leading Fertility Technology 3
... zero in (on) the modalities of a drug, capable of ... trials on animal models have revealed the capacity of the ... charge of energy production., ,'Many drugs block the ... who is the Werner E. Bachmann Collegiate Professor of Chemistry ...
... renowned medical specialist, NHS can be freed from its’ ... reconsidered before they are implemented. // It is amply ... may make matters worse for the deprived and under ... has led to low morale among Doctors and NHS ...
... has announced the launch of BARACLUDE? (entecavir) for ... its approval by the Drug Controller General of India. ... of chronic hepatitis B virus infection in adults with ... persistent elevations in serum aminotransferases (ALT or AST) or ...
... warned that hospitals are repeatedly failing to implement rules ... to patients //from contaminated surgical instruments. ,The ... in sets so they can be traced easily. Instead ... ,Dr Gill Morgan, chief executive of the NHS ...
... with medical services functioning smoothly and the institute's director ... and attending to patients - a day after the ... ,While health services normalised in AIIMS after doctors, ... their agitation last evening following the court order, the ...
... diseases that has affected everyone from Henry VIII to Christoper ... near the site of infection//. The primary sore first appears ... clear. , This is followed by generalized skin rash, ... few months or years later tertiary syphilis develops which destroys ...
Cached Medicine News:Health News:Autoimmune disorders studied in detail by U-M researchers. 2Health News:India Approves Baraclude? (entecavir) For ,Treatment Of Chronic HEPATITIS B 2
(Date:5/5/2015)... May 05, 2015 Research and Markets ... "Home Healthcare Global Market - Forecast to 2020" ... healthcare market is expected to reach more than $300+ ... The home healthcare equipment market is expected to ... services market. Home healthcare is gaining a tremendous attention ...
(Date:5/5/2015)... , May 5, 2015 Lymphatic pump ... with antibiotic treatment, according to a new study published ... Researchers performed LPT on infected ... levofloxacin, a popular antibiotic used to treat pneumonia. After ... disease free compared to only 25 percent of rats ...
(Date:5/5/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ... company focused on the development of oral drug ... present at the following conferences in May 2015: ... ,Date:            May 10, ... Officer ,Time:            1:45 ...
Breaking Medicine Technology:Global Home Healthcare Global Market 2015 - Forecast to 2020 for the $300 Billion Market 2Lymphatic Pump Treatment Enhances Antibiotic Effectiveness for Treating Pneumonia 2Oramed to Present at Upcoming Conferences 2Oramed to Present at Upcoming Conferences 3
... Calif. , July 15 Premier Inc., ... 67,000-plus other healthcare sites working together to achieve high ... of FDA-cleared Electronic Brachytherapy Systems, announced the execution of ... three-year contract for brachytherapy systems with Premier Purchasing Partners ...
... At the 2010 American Association of Physicists in Medicine (AAPM) ... , Elekta (booth #101) will showcase its broad array of ... Image Guided Radiation Therapy. , ... "At Elekta, intelligent solutions originate from collaboration with medical ...
Cached Medicine Technology:Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy 2Xoft Announces Exclusive Contract With Premier for Electronic Brachytherapy 3Elekta to Highlight Intelligent Cancer Management Solutions at 2010 AAPM Annual Meeting 2Elekta to Highlight Intelligent Cancer Management Solutions at 2010 AAPM Annual Meeting 3Elekta to Highlight Intelligent Cancer Management Solutions at 2010 AAPM Annual Meeting 4
Heavy curved shafts with 2 x 2 teeth and crisscross serrated 6 mm tying platform. Serrated handle with polished finish....
Serrated, 10 mm tips angled 30 degrees. Serrated cross action handle with polished finish....
Smooth 90 degree jaws with locking screw maintain proper stretch of sleeve for securing silicone bands....
Ergotec Vetriretinal Instrument System. 2 mm pointed black tips with 0.6 mm platform. 20 gauge shaft tapers to 23 gauge....
Medicine Products: